| Literature DB >> 31883027 |
Michaëla A M Huson1, Dan Kaminstein2, Daniel Kahn3, Sabine Belard4,5, Prakash Ganesh6,7, Vanessa Kandoole-Kabwere8, Claudia Wallrauch9, Sam Phiri6,10,11,12, Benno Kreuels8,13, Tom Heller14.
Abstract
BACKGROUND: Point-of-care ultrasound is increasingly being used as a diagnostic tool in resource-limited settings. The majority of existing ultrasound protocols have been developed and implemented in high-resource settings. In sub-Saharan Africa (SSA), patients with heart failure of various etiologies commonly present late in the disease process, with a similar syndrome of dyspnea, edema and cardiomegaly on chest X-ray. The causes of heart failure in SSA differ from those in high-resource settings. Point-of-care ultrasound has the potential to identify the underlying etiology of heart failure, and lead to targeted therapy. Based on a literature review and weighted score of disease prevalence, diagnostic impact and difficulty in performing the ultrasound, we propose a context-specific cardiac ultrasound protocol to help differentiate patients presenting with heart failure in SSA.Entities:
Keywords: Africa; Cardiac ultrasound; POCUS; Protocol; Resource-limited setting
Year: 2019 PMID: 31883027 PMCID: PMC6934640 DOI: 10.1186/s13089-019-0149-0
Source DB: PubMed Journal: Ultrasound J ISSN: 2524-8987
Weighting of prevalence, diagnostic impact and difficulty of POCUS applications
| Weight | Disease prevalence | Diagnostic impact of US | US difficulty and technical requirements |
|---|---|---|---|
| 1 | Rare (< 5%) | Minor or no management change | Technically advanced, often requiring special equipment like TEE probe, cw-Doppler, cardiac software |
| 2 | Relatively common (5–15%) | Management change | Moderate, may require color-Doppler |
| 3 | Very common (> 15%) | Urgent management change (possibly life threatening) | Technically easy, only basic b/w US |
For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty, scoring is reversed with numbers indicating the following levels: 1 = high, 2 = medium, and 3 = low. This allows for a composite score where the higher numbers correspond to increasing relevance and applicability of POCUS
US ultrasound, TEE transesophageal echocardiography, cw continuous wave, b/w black and white
Fig. 1Geographic area of the 18 included studies on frequency of causes of cardiac failure. Note that some studies included multiple sites. Therefore, there are more study sites in the figure than included studies
Etiology of heart failure in sub-Saharan Africa
| First author, year | Patients with HF ( | Hypertension (%) | Dilated cardiomyopathy (%)a | Ischemic (%) | Valvular (%) | Right-sided HF/cor pulmonale (%) | Effusion (%) | Endomyocardial fibrosis (%) | Congenital (%) |
|---|---|---|---|---|---|---|---|---|---|
| Ansa, 2016 | 339 | 48.6 | 35.4 | 1.4 | |||||
| Appiah, 2017 | 1916 | 52.3 | 19.8 | 4 | 7.6 | 0.4 | |||
| Bonsu, 2017 | 1488 | 61.2 | 19.9 | 12.9 | |||||
| Boombhi, 2017 | 148 | 30.2 | 28.6 | 6.4 | 11.9 | 8.7 | 4 | ||
| Damasceno, 2012 | 1006 | 45.4 | 18.8 | 7.7 | 14.3 | 6.8 | 1.3 | ||
| Dokainish, 2017 | 1294 | 35 | 14.2 | 20 | 11 | 0.1 | |||
| Kingery, 2017 | 588 | 42.8 | 19.3 | 6.2 | 16.6 | 7.6 | |||
| Kwan, 2013 | 192 | 8 | 54 | 25 | 1.4 | 0.7 | 5 | ||
| Makubi, 2014 | 427 | 45 | 22.4 | 9 | 12 | ||||
| Massoure, 2013 | 45 | 13 | 7 | 62 | |||||
| Mwita, 2017 | 193 | 40.4 | 19.6 | 5.7 | 9.3 | 6.2 | |||
| Nkoke, 2017 | 529 | 43.2 | 17.6 | 9.6 | 11.7 | 8.8 | 3.8 | 2.1 | |
| Ogah, 2013 | 452 | 78.5 | 7.5 | 0.4 | 2.4 | 4.4 | 3.3 | 0.9 | 0.4 |
| Ojji, 2013 | 1515 | 60.6 | 12 | 0.4 | 9.4 | ||||
| Onwuchekwa, 2009 | 423 | 56.3 | 7.3 | 0.2 | 4.3 | 2.1 | |||
| Pio, 2014 | 297 | 43.1 | 5.9 | 19.2 | 11.8 | 2.7 | 1.7 | 2.7 | |
| Stewart, 2008 | 844 | 33 | 28 | 9 | 8 | 27 |
HF heart failure
aThe majority of this group consists of idiopathic dilated cardiomyopathy. Peripartum cardiomyopathy and HIV-related cardiomyopathy were mentioned in several studies, while thyrotoxicosis, alcohol and diabetes were mentioned incidentally as causes for dilated cardiomyopathy
Ranking of cardiac ultrasound applications according to prevalence, impact and difficulty
| Echocardiographic finding | Prevalence (P) | Impact (I) | Difficulty (D) | PxIxD | Rank |
|---|---|---|---|---|---|
| LV hypertrophy | 3 | 2 | 2 | 12 | 1 |
| Rheumatic mitral disease (stenosis suggested by large LA) | 2 | 2 | 3 | 12 | 1 |
| Cardiomyopathy, severe | 3 | 2 | 2 | 12 | 1 |
| Cor pulmonale | 2 | 2 | 3 | 12 | 1 |
| Pericardial effusion | 1 | 3 | 3 | 9 | 2 |
| Regurgitation (MV, AV, TV by color Doppler) | 2 | 2 | 2 | 8 | 3 |
| Rheumatic mitral stenosis (valve morphology only) | 2 | 2 | 1 | 4 | 4 |
| Rheumatic aortic stenosis (valve morphology only) | 2 | 2 | 1 | 2 | 4 |
| Endocarditis (large vegetations seen on TTE) | 1 | 2 | 2 | 4 | 4 |
| RV function grading (e.g., TAPSE) | 2 | 2 | 1 | 4 | 4 |
| Mitral stenosis grading (PHT) | 2 | 2 | 1 | 4 | 4 |
| Aortic stenosis grading (continuation equation) | 2 | 2 | 1 | 4 | 4 |
| Regional hypokinesia | 2 | 2 | 1 | 4 | 4 |
| LV function grading (e.g., ejection fraction) | 3 | 1 | 1 | 3 | 5 |
| Endocarditis (TEE) | 1 | 2 | 1 | 2 | 6 |
| Endomyocardial fibrosis | 1 | 1 | 2 | 2 | 6 |
| Congenital heart diseases | 1 | 2 | 1 | 2 | 6 |
| Pulmonary artery pressure (dTR) | 2 | 1 | 1 | 2 | 6 |
For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty, scoring is reversed with numbers indicating the following levels: 1 = high, 2 = medium, and 3 = low. For prevalence and impact the numbers indicate the following levels: 1 = low, 2 = medium, 3 = high. For difficulty scoring is reversed with numbers indicating the following levels: 1 = high, 2 = medium, and 3 = low. This allows for a composite score where the higher numbers correspond to increasing relevance and applicability of POCUS
LV left ventricular, LA left atrium, MV mitral valve, AV aortic valve, TV tricuspid valve, TEE transesophageal echocardiogram, RV right ventricle, TAPSE tricuspid annular plane systolic excursion, PHT pressure half-time, dTR pressure gradient measured in tricuspid regurgitation
Clinical signs of heart failure or cardiomegaly on chest X-ray: narrowing differential diagnoses by cardiac ultrasound to guide management/and respective management (video clips of a normal heart and for each pattern are available as Additional file 2)
| Ultrasound image | Effusion | Dilated CMP | Right-sided heart failure | Valvular (mitral) | LV Hypertrophy |
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
|
|
|
|
| |
| Scanning method | Subxiphoid view Optional: 4-chamber view | Subxiphoid view Optional: 4-chamber view | Subxiphoid view Optional: 4-chamber view, parasternal short | Subxiphoid view Optional: 4-chamber view, parasternal long | Subxiphoid view Optional: parasternal long |
| Key US features | Anechoic fluid surrounding the hearta In severe cases collapse of RV (tamponade) | Reduced inward movement of the LV wall Generalized dilatation of both atria and ventricles | Dilated RV in comparison to the left (ratio > 0.7) D-shaped LV in the parasternal short axis | Dilated LA Thickened mitral valve Mitral regurgitation on Doppler | Thickened LV (septum > 12 mm) Dilated LA Possibly secondary dilated right heart |
| Differential diagnosis | TB Malignancy Uremia Massive fluid overload Viral Auto-immune | HIV CMP Idiopathic dilated CMP (post-infectious) Peripartum CMP Alcoholic CMP Ischemic heart disease (severe) | Pulmonary embolism Pulmonary hypertension of other cause | Rheumatic heart disease | Hypertension Aortic stenosis Genetic hypertrophic CMP |
RV right ventricle, LV left ventricle, LA left atrium, CMP cardiomyopathy, TB tuberculosis, HIV human immunodeficiency virus
aUse the parasternal long axis to differentiate between pleural and pericardial effusions. Pericardial effusions continue anterior to the descending aorta, whereas pleural effusions are found posterior to the descending aorta
| CURLS protocol: 5 questions | Interpretation |
|---|---|
| 1. Is a pericardial effusion present? | Yes: consider cardiac tamponade No: consider alternative cause of heart failure |
| 2. Is the left ventricular function reduced? | Yes: consider cardiomyopathy of various causes No: consider alternative cause of heart failure |
| 3. Is the right ventricle larger than the left ventricle? | Yes: consider pulmonary artery hypertension or pulmonary embolism No: consider alternative cause of heart failure |
| 4. Is the left atrium larger than the left ventricle? | Yes: consider mitral stenosis or regurgitation, possibly caused by rheumatic heart disease No: Consider alternative cause of heart failure |
| 5. Is the left ventricle wall (septum) thicker than 12 mm? | Yes: consider hypertension, or aortic stenosis/regurgitation No: consider alternative cause of heart failure |